These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32101280)

  • 21. Pentagon drawing and neuropsychological performance in Dementia with Lewy Bodies, Alzheimer's disease, Parkinson's disease and Parkinson's disease with dementia.
    Cormack F; Aarsland D; Ballard C; Tovée MJ
    Int J Geriatr Psychiatry; 2004 Apr; 19(4):371-7. PubMed ID: 15065231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed matching to sample task 48: assessment of malingering with simulating design.
    Nikolai T; Cechova K; Bukacova K; Fendrych Mazancova A; Markova H; Bezdicek O; Hort J; Vyhnalek M
    Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2021 Nov; 28(6):797-811. PubMed ID: 32998629
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-Disease Validation of the RUDAS for Cognitive Screening in Alzheimer's Disease, Parkinson's Disease, and Multiple Sclerosis.
    Delgado-Álvarez A; Díez-Cirarda M; Delgado-Alonso C; Hernández-Lorenzo L; Cuevas C; Valles-Salgado M; Montero-Escribano P; Gil-Moreno MJ; Matías-Guiu J; García-Ramos R; Matias-Guiu JA
    J Alzheimers Dis; 2023; 91(2):705-717. PubMed ID: 36502332
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain age and Alzheimer's-like atrophy are domain-specific predictors of cognitive impairment in Parkinson's disease.
    Charissé D; Erus G; Pomponio R; Gorges M; Schmidt N; Schneider C; Liepelt-Scarfone I; Riedel O; Reetz K; Schulz JB; Berg D; Storch A; Witt K; Dodel R; Kalbe E; Kassubek J; Hilker-Roggendorf R; Baudrexel S
    Neurobiol Aging; 2022 Jan; 109():31-42. PubMed ID: 34649002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of the Spanish Version of the LASSI-L for Diagnosing Mild Cognitive Impairment and Alzheimer's Disease.
    Matías-Guiu JA; Curiel RE; Rognoni T; Valles-Salgado M; Fernández-Matarrubia M; Hariramani R; Fernández-Castro A; Moreno-Ramos T; Loewenstein DA; Matías-Guiu J
    J Alzheimers Dis; 2017; 56(2):733-742. PubMed ID: 27983554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropsychological and psychiatric differences between Alzheimer's disease and Parkinson's disease with dementia.
    Starkstein SE; Sabe L; Petracca G; Chemerinski E; Kuzis G; Merello M; Leiguarda R
    J Neurol Neurosurg Psychiatry; 1996 Oct; 61(4):381-7. PubMed ID: 8890777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychometric Properties of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson's Disease.
    Gallagher J; Rick J; Xie SX; Martinez-Martin P; Mamikonyan E; Chen-Plotkin A; Dahodwala N; Morley J; Duda JE; Trojanowski JQ; Siderowf A; Weintraub D
    J Parkinsons Dis; 2021; 11(2):737-745. PubMed ID: 33386814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Olfaction as an early marker of Parkinson's disease and Alzheimer's disease.
    Walker IM; Fullard ME; Morley JF; Duda JE
    Handb Clin Neurol; 2021; 182():317-329. PubMed ID: 34266602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emotional prosody recognition is impaired in Alzheimer's disease.
    Amlerova J; Laczó J; Nedelska Z; Laczó M; Vyhnálek M; Zhang B; Sheardova K; Angelucci F; Andel R; Hort J
    Alzheimers Res Ther; 2022 Apr; 14(1):50. PubMed ID: 35382868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer's disease.
    Vipin A; Loke YM; Liu S; Hilal S; Shim HY; Xu X; Tan BY; Venketasubramanian N; Chen CL; Zhou J
    Alzheimers Res Ther; 2018 Aug; 10(1):82. PubMed ID: 30121086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Social cognition and social functioning in patients with amnestic mild cognitive impairment or Alzheimer's dementia.
    Kessels RPC; Waanders-Oude Elferink M; van Tilborg I
    J Neuropsychol; 2021 Jun; 15(2):186-203. PubMed ID: 32979297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Comparison of naming impairment among patients with Parkinson's disease without dementia, Parkinson's disease dementia and Alzheimer's disease].
    Gui XH; Wang LP; Wu CL; Sun XF
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(21):1664-7. PubMed ID: 27290706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detecting the Cognitive Prodrome of Dementia in Parkinson's Disease.
    De Roy J; Postuma RB; Brillon-Corbeil M; Montplaisir J; Génier Marchand D; Escudier F; Panisset M; Chouinard S; Gagnon JF
    J Parkinsons Dis; 2020; 10(3):1033-1046. PubMed ID: 32310188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Memory performance on the story recall test and prediction of cognitive dysfunction progression in mild cognitive impairment and Alzheimer's dementia.
    Park JH; Park H; Sohn SW; Kim S; Park KW
    Geriatr Gerontol Int; 2017 Oct; 17(10):1603-1609. PubMed ID: 27910252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Utility of the Envelope Task in Mild Cognitive Impairment and Dementia.
    Marcone S; Gagnon JF; Lecomte S; Imbeault H; Limoges F; Postuma RB; Bertrand JA; Joubert S; Rouleau I
    Can J Neurol Sci; 2017 Jan; 44(1):9-16. PubMed ID: 27665668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A review of cognitive impairments in dementia with Lewy bodies relative to Alzheimer's disease and Parkinson's disease with dementia.
    Metzler-Baddeley C
    Cortex; 2007 Jul; 43(5):583-600. PubMed ID: 17715794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive performance in healthy clinical trial participants and patients with the NeuroCart, a neurodegenerative disease measured with an automated neuropsychological and neurophysiological test battery.
    Prins S; Borghans L; de Kam ML; Groeneveld GJ; van Gerven J
    J Neurol Sci; 2023 Jun; 449():120658. PubMed ID: 37079973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.